Using CRISPR to Reverse Retinitis Pigmentosa and Restore Visual Function

Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.

Provided by EUPB - Read the full story at the source site.
Read The Full Story

Top News